1. bookVolume 67 (2017): Edizione 3 (September 2017)
Dettagli della rivista
License
Formato
Rivista
eISSN
1846-9558
Prima pubblicazione
28 Feb 2007
Frequenza di pubblicazione
4 volte all'anno
Lingue
Inglese
Accesso libero

Curcumin: Synthesis optimization and in silico interaction with cyclin dependent kinase

Pubblicato online: 30 Aug 2017
Volume & Edizione: Volume 67 (2017) - Edizione 3 (September 2017)
Pagine: 385 - 395
Accettato: 04 Apr 2017
Dettagli della rivista
License
Formato
Rivista
eISSN
1846-9558
Prima pubblicazione
28 Feb 2007
Frequenza di pubblicazione
4 volte all'anno
Lingue
Inglese

1. C. Ireson, S. Orr, D. J. Jones, R. Verschoyle, C.-K. Lim, J.-L. Luo, L. Howells, S. Plummer, R. Jukes and M. Williams, Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production, Cancer Res.61 (2001) 1058–1064.Search in Google Scholar

2. T. N. Almanaa, M. E. Geusz and R. J. Jamasbi, Effects of curcumin on stem-like cells in human esophageal squamous carcinoma cell lines, BMC Complement. Altern. Med.12 (2012) 1–15 DOI: 10.1186/1472-6882-12-195.10.1186/1472-6882-12-195352843723095512Search in Google Scholar

3. B. B. Aggarwal, S. C. Gupta and B. Sung, Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers, Br. J. Pharmacol.169 (2013) 1672–1692; DOI: 10.1111/bph.12131.10.1111/bph.12131375382923425071Search in Google Scholar

4. A. B. Kunnumakkara, P. Anand and B. B. Aggarwal, Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins, Cancer Lett.269 (2008) 199–225; DOI: 10.1016/j.canlet.2008.03.009.10.1016/j.canlet.2008.03.00918479807Search in Google Scholar

5. T.-F. Jiang, Y.-J. Zhang, H.-Y. Zhou, H.-M. Wang, L.-P. Tian, J. Liu, J.-Q. Ding and S.-D. Chen, Curcumin ameliorates the neurodegenerative pathology in A53T α-synuclein cell model of Parkinson’s disease through the downregulation of mTOR/p70S6K signaling and the recovery of macroautophagy, J. Neuroimmune Pharmacol.8 (2013) 356–369; DOI: 10.1007/s11481-012-9431-7.10.1007/s11481-012-9431-723325107Search in Google Scholar

6. C. N. Conteas, A. M. Panossian, T. T. Tran and H. M. Singh, Treatment of HIV-associated diarrhea with curcumin, Dig. Dis. Sci.54 (2009) 2188–2191; DOI: 10.1007/s10620-008-0597-z.10.1007/s10620-008-0597-z19051018Search in Google Scholar

7. L. X. Na, Y. Li, H. Z. Pan, X. L. Zhou, D. J. Sun, M. Meng, X. X. Li and C. H. Sun, Curcuminoids exert glucose-lowering effect in type 2 diabetes by decreasing serum free fatty acids: a double-blind, placebo-controlled trial, Mol. Nutr. Food Res.57 (2013) 1569–1577; DOI: 10.1002/mnfr.201200131.10.1002/mnfr.20120013122930403Search in Google Scholar

8. M. Garcia-Alloza, L. Borrelli, A. Rozkalne, B. Hyman and B. Bacskai, Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model, J. Neurochem.102 (2007) 1095–1104; DOI: 10.1111/j.1471-4159.2007.04613.x.10.1111/j.1471-4159.2007.04613.x17472706Search in Google Scholar

9. S. Shishodia, T. Singh and M. M. Chaturvedi, Modulation of Transcription Factors by curcumin, in The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease (Eds. B. B. Aggarwal, Y.-J. Surh and S. Shishodia) (Series: Advances in Experimental Medicine and Biology, Vol. 595), Springer, New York 2007, pp. 27–148.Search in Google Scholar

10. N. Handler, W. Jaeger, H. Puschacher, K. Leisser and T. Erker, Synthesis of novel curcumin analogues and their evaluation as selective cyclooxygenase-1 (COX-1) inhibitors, Chem. Pharm. Bull.55 (2007) 64–71; DOI: 10.1248/cpb.55.64.10.1248/cpb.55.6417202703Search in Google Scholar

11. Y. Bustanji, M. O. Taha, I. M. Almasri, M. A. Al-Ghussein, M. K. Mohammad and H. S. Alkhatib, Inhibition of glycogen synthase kinase by curcumin: Investigation by simulated molecular docking and subsequent in vitro/in vivo evaluation, J. Enzyme Inhib. Med. Chem.24 (2009) 771–778; DOI: 10.1080/14756360802364377.10.1080/1475636080236437718720192Search in Google Scholar

12. K. E. Sheppard and G. A. McArthur, The cell-cycle regulator CDK4: an emerging therapeutic target in melanoma, Clin. Cancer Res.19 (2013) 5320–5328; DOI: 10.1158/1078-0432.CCR-13-0259.10.1158/1078-0432.CCR-13-025924089445Search in Google Scholar

13. Hypercube Inc, HyperChem(TM) Professional 8.014 Hypercube, Gainesville (FL) 2008.Search in Google Scholar

14. G. Jones, P. Willett, R.C. Glen, A.R. Leach and R. Taylor, Development and validation of a genetic algorithm for flexible docking, J. Mol. Biol.267 (1997) 727–748; DOI: 10.1006/jmbi.1996.0897.10.1006/jmbi.1996.08979126849Search in Google Scholar

15. S. Kawano, Y. Inohana, Y. Hashi and J.-M. Lin, Analysis of keto-enol tautomers of curcumin by liquid chromatography/mass spectrometry, Chin. Chem. Lett.24 (2013) 685–687; DOI: 10.1016/j.cclet.2013.05.006.10.1016/j.cclet.2013.05.006Search in Google Scholar

Articoli consigliati da Trend MD

Pianifica la tua conferenza remota con Sciendo